Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Species
- (2)
- (2)
- (6)
- (6)
- (6)
- (6)
- (2)
- (13)
- (1,863)
- (104)
- (1)
- (1)
- (4)
- (52)
- (2)
- (5)
- (9)
- (2)
- (15)
- (1)
- (29)
- (450)
- (8)
- (8)
- (27)
- (1)
- (28,449)
- (1)
- (8)
- (3)
- (15)
- (1)
- (3)
- (13)
- (1)
- (7)
- (1)
- (5)
- (2)
- (3)
- (4)
- (3)
- (2)
- (11)
- (3)
- (3)
- (4)
- (4)
- (2)
- (2)
- (2)
- (1)
- (4)
- (1)
- (39,386)
- (196)
- (47)
- (19)
- (17)
- (8)
- (4)
- (1)
- (3)
- (2)
- (6)
- (211)
- (2)
- (3)
- (2,151)
- (18)
- (2)
- (1)
- (2)
- (14)
- (1)
- (52)
- (2)
- (2)
- (2)
- (1)
- (42)
- (39)
- (44)
- (31)
- (2)
- (61)
- (4)
- (370)
- (8)
- (172)
- (13)
- (12)
- (3)
- (6)
- (4)
- (139)
- (4)
- (3)
- (3)
- (2)
- (2)
- (2)
- (14)
- (30,025)
- (4)
- (4,513)
- (2)
- (1)
- (7)
Regulatory Status
- (85)
- (105,537)
For Use With (Application)
- (2)
- (1)
- (3,448)
- (1)
- (28,534)
- (1)
- (65)
- (548)
- (9,419)
- (24)
- (1)
- (8)
- (2)
- (8)
- (5)
- (2)
- (2)
- (13)
- (1)
- (2)
- (235)
- (2)
- (2)
- (2)
- (1)
- (2)
- (2)
- (3)
- (1)
- (1)
- (5)
- (1)
- (1)
- (248)
- (3)
- (27,119)
- (1)
- (1)
- (1)
- (35)
- (3)
- (50,527)
- (1,378)
- (2)
- (4)
- (8)
- (41)
- (790)
- (4)
- (3)
- (2)
- (1)
- (133)
- (361)
- (4,262)
- (3)
- (68)
- (7)
- (1,461)
- (4)
- (19,645)
- (26)
- (2)
- (32)
- (19)
- (182)
- (20)
- (3)
- (117)
- (150)
- (98)
- (3)
- (1)
- (15)
- (21)
- (3)
- (1)
- (1,605)
- (1)
- (4)
- (1)
- (35)
- (2,556)
- (2)
- (1)
- (2)
- (2)
- (9)
- (11)
- (2)
- (21,928)
- (4,209)
- (3)
- (4)
- (5)
- (5)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (47,864)
- (5)
- (2)
- (1)
- (62)
- (4)
- (5)
- (3)
- (1)
- (6)
- (1)
- (1)
- (18,249)
- (4)
- (164)
- (1)
- (14)
- (13)
- (2)
- (4)
- (14)
- (5)
- (5)
- (1)
- (51,375)
- (1,912)
Recombinant
- (24)
- (78,884)
- (12)
Form
- (3)
- (3)
- (57,208)
- (10,887)
- (3,526)
- (144)
- (39)
- (3,404)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
1
–
15
of
91,135
results
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human EGF |
| Purification Method | Purified |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | EGF |
| Storage Requirements | 4°C |
| Protein Subtype | EGF (Epidermal Growth Factor) |
| Accession Number | P01133 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 1950 |
| Product Line | Gibco |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TGF beta-1 |
| Molecular Weight (g/mol) | 25 kDa |
| Gene Symbol | Tgfb1 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYNQHNP GASAAPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | HEK293 cells |
| Name | Human TGF-beta 1 |
| Accession Number | P01137 |
| Gene Alias | CED; cytokine; DPD1; LAP; Latency-associated peptide; prepro-transforming growth factor beta-1; regulatory protein; TGF b; TGF b 1; TGF beta; tgf beta 1; tgf beta1; TGF beta-1; TGF beta-1 protein; TGF β; TGF β 1; TGF β1; Tgfb; TGFB1; TGF-B1; Tgfb-1; TGFbeta; TGF-beta 1; TGF-beta 1 protein; TGFbeta1; TGF-beta1; TGF-beta-1; TGFβ1; Transforming growth factor; transforming growth factor b1; transforming growth factor beta; transforming growth factor beta 1; transforming growth factor beta-1; Transforming growth factor beta-1 proprotein; transforming growth factor beta-1 proprotein; transforming growth factor beta-1; transforming growth factor β1; transforming growth factor, beta 1; transforming growth factor, beta 1 (Camurati-Engelmann disease); transforming growth factor, beta-1; transforming growth factor-beta 1; transforming growth factor-beta I; transforming growth factor-beta-1; transforming growth factor-beta-1 precursor; unnamed protein product |
| Biological Activity | The ED50 was determined by TGF-beta1's ability to inhibit the mouse IL-4-dependent proliferation of mouse HT-2 cells is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Gene ID (Entrez) | 7040 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
Promotions Available
Gibco™ Human/Mouse/Rat BDNF Recombinant Protein, PeproTech®
Gibco™ Human/Mouse/Rat BDNF Recombinant Protein, PeproTech®
Recombinant Protein
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | BDNF |
| Molecular Weight (g/mol) | 27 kDa |
| Gene Symbol | BDNF |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MHSDPARRGE LSVCDSISEW VTAADKKTAV DMSGGTVTVL EKVPVSKGQL KQYFYETKCN PMGYTKEGCR GIDKRHWNSQ CRTTQSYVRA LTMDSKKRIG WRFIRIDTSC VCTLTIKRGR |
| Expression System | E. coli |
| For Use With (Application) | Binding Assay,Bioactivity,Control,ELISA Standard,Western Blot Control |
| Source | E. coli |
| Name | Human/Mouse/Rat BDNF |
| Accession Number | P21237, P23363, P23560 |
| Gene Alias | abrineurin; ANON2; anorexia BDNF; Bdnf; BDNF precursor form; bdnf protein; brain derived neurothrophic factor; brain derived neurotrophic factor; brain-derived neurotrophic factor; BULN2; H-BDNF; neurotrophin; ProBDNF |
| Biological Activity | Determined by its ability to bind recombinant human TrkB Fc Chimera in a functional ELISA. |
| Gene ID (Entrez) | 12064, 24225, 627 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
Promotions Available
Gibco™ Human EGF, Animal-Free Recombinant Protein, PeproTech®
Gibco™ Human EGF, Animal-Free Recombinant Protein, PeproTech®
Recombinant Protein
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Gene Symbol | EGF |
| Endotoxin Concentration | <0.1 EU/μg |
| Sequence | NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human EGF, Animal-Free |
| Accession Number | P01133 |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Biological Activity | The ED50 was determined by a cell proliferation assay using balb/c 3T3 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 1950 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | M-CSF |
| Molecular Weight (g/mol) | 36.8 kDa |
| Gene Symbol | Csf1 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MEEVSEYCSH MIGSGHLQSL QRLIDSQMET SCQITFEFVD QEQLKDPVCY LKKAFLLVQD IMEDTMRFRD NTPNAIAIVQ LQELSLRLKS CFTKDYEEHD KACVRTFYET PLQLLEKVKN VFNETKNLLD KDWNIFSKNC NNSFAECSSQ GHERQSEGS |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | E. coli |
| Name | Human M-CSF |
| Accession Number | P09603 |
| Gene Alias | C87615; colony stimulating factor 1; colony stimulating factor 1 (macrophage); colony-stimulating factor-1 splice variant; CSF1; CSF-1; Csfm; H-MCSF; lanimostim; macrophage colony stimulating factor 1; macrophage colony stimulating factor alpha; macrophage colony stimulating factor beta; macrophage colony-stimulating factor; macrophage colony-stimulating factor 1; macrophage colony-stimulating factor beta; macrophage-colony stimulating factor alpha; MCSF; MCSF alpha; MCSFBETA; MGC31930; M-MCSF; op; osteopetrosis; Processed macrophage colony-stimulating factor 1 |
| Biological Activity | The ED50 was determined by the dose-dependent stimulation of the proliferation of murine M-NSF-60 cells ≤ 1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 1435 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | GDNF |
| Molecular Weight (g/mol) | 30.4 kDa |
| Gene Symbol | GDNF |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MSPDKQMAVL PRRERNRQAA AANPENSRGK GRRGQRGKNR GCVLTAIHLN VTDLGLGYET KEELIFRYCS GSCDAAETTY DKILKNLSRN RRLVSDKVGQ ACCRPIAFDD DLSFLDDNLV YHILRKHSAK RCGCI |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,Western Blot Control |
| Source | E. coli |
| Name | Human GDNF |
| Accession Number | P39905 |
| Gene Alias | AI385739; Astrocyte-derived trophic factor; ATF; ATF1; ATF2; Gdnf; glial cell derived neurotrophic factor; glial cell line derived neurotrophic factor; Glial cell line derived neutrophic factor; glial cell line-derived neurotrophic factor; gndf; HFB1-GDNF; hGDNF; H-GDNF; HSCR3; mGDNF; neurotrophic factor |
| Biological Activity | Determined by a cell proliferation assay using SH-SY5Y cells. The expected ED50 for this effect is 1.0-10.0 ng/ml |
| Gene ID (Entrez) | 2668 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 26.7 kDa |
| Common Name | RSPO1 |
| Gene Symbol | RSPO1 |
| Activity | R-Spondin-1 enhances BMP-2-mediated differentiation of MC3T3-E1 cells. The expected ED50 is 1.0-3.0 ug/ml. |
| Endotoxin Concentration | <1 EU/μg |
| Storage Requirements | -20°C |
| Sequence | SRGIKGKRQR RISAEGSQAC AKGCELCSEV NGCLKCSPKL FILLERNDIR QVGVCLPSCP PGYFDARNPD MNKCIKCKIE HCEACFSHNF CTKCKEGLYL HKGRCYPACP EGSSAANGTM ECSSPAQCEM SEWSPWGPCS KKQQLCGFRR GSEERTRRVL HAPVGDHAAC SDTKETRRCT VRRVPCPEGQ KRRKGGQGRR ENANRNLARK ESKEAGAGSR RRKGQQQQQQ QGTVGPLTSA GPA |
| Expression System | CHO cells |
| For Use With (Application) | Bioactivity,Control |
| Name | Human R-Spondin 1 |
| Accession Number | Q2MKA7 |
| Purification Method | Purified |
| Gene Alias | CRISTIN3; cristin-3; cysteine-rich and single thrombospondin domain-containing protein 3; FLJ40906; hRspo1; mCristin-3; RGD1565558; Roof plate-specific spondin-1; RP11-566C13.1; RSPO; RSPO1; Rspondin; R-spondin; R-spondin 1; R-spondin homolog; R-spondin homolog (Xenopus laevis); R-spondin-1; thrombospondin type 1 domain containing gene Rspondin |
| Product Type | Protein |
| Gene ID (Entrez) | 284654 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
Promotions Available
Gibco™ Human FGF-basic (FGF-2/bFGF) (154 aa) Recombinant Protein, PeproTech®
Gibco™ Human FGF-basic (FGF-2/bFGF) (154 aa) Recombinant Protein, PeproTech®
Recombinant Protein
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17.2 kDa |
| Gene Symbol | FGF2 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | AAGSITTLPA LPEDGGSGAF PPGHFKDPKR LYCKNGGFFL RIHPDGRVDG VREKSDPHIK LQLQAEERGV VSIKGVCANR YLAMKEDGRL LASKCVTDEC FFFERLESNN YNTYRSRKYT SWYVALKRTG QYKLGSKTGP GQKAILFLPM SAKS |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human FGF-basic (FGF-2/bFGF) (154 aa) |
| Accession Number | P09038 |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Biological Activity | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 2247 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IFN gamma |
| Molecular Weight (g/mol) | 16.8 kDa |
| Gene Symbol | IFNG |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN FKDDQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE LSPAAKTGKR KRSQMLFQGR RASQ |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human IFN-gamma |
| Accession Number | P01579 |
| Gene Alias | BoIFNG; cytokine; EGK_03901; gamma interferon; gamma interferon precursor; gamma-interferon; gamma-interferon precursor (AA -23 to 143); H-IFN-g; IFG; IFI; IFN gamma; IFN γ; Ifng; IFN-g; IFNG2; IFN-gamma; IFN-gamma precursor; IFN-y; IFNγ; Immune interferon; Interferon; interferon gamma; interferon gamma precursor; interferon gamma type 2; Interferon y; Interferon γ; interferon, gamma; interferon-gama; interferon-gamma; Interferon-gamma level; interferon-gamma precursor; Interferonγ; M-IFN-g; R-IFN-g |
| Biological Activity | The ED50 determined by a cytotoxicity assay using HT-29 cells is = 0.05 ng/ml, corresponding to a specific activity of = 2 x 10^7 units/mg |
| Gene ID (Entrez) | 3458 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | VEGF-165 |
| Molecular Weight (g/mol) | 38.2 kDa |
| Gene Symbol | Vegfa |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | E. coli |
| Name | Human VEGF-165 |
| Accession Number | P15692 |
| Gene Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Biological Activity | Determined by its ability to stimulate the proliferation of human umbilical vein endothelial cells (HUVEC). The expected ED50 for this effect is 1.0-10.0 ng/ml |
| Gene ID (Entrez) | 7422 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 52.5 kDa |
| Common Name | IL-34 |
| Gene Symbol | Il34 |
| Activity | Measured by its ability to induce secretion of MCP-1 from PBMCs. |
| Endotoxin Concentration | <1 EU/μg |
| Storage Requirements | -20°C |
| Sequence | NEPLEMWPLT QNEECTVTGF LRDKLQYRSR LQYMKHYFPI NYKISVPYEG VFRIANVTRL QRAQVSEREL RYLWVLVSLS ATESVQDVLL EGHPSWKYLQ EVETLLLNVQ QGLTDVEVSP KVESVLSLLN APGPNLKLVR PKALLDNCFR VMELLYCSCC KQSSVLNWQD CEVPSPQSCS PEPSLQYAAT QLYPPPPWSP SSPPHSTGSV RPVRAQGEGL LPHHHHHHHH |
| Expression System | HEK293 cells |
| For Use With (Application) | Bioactivity,Control |
| Name | Human IL-34 |
| Accession Number | Q6ZMJ4 |
| Purification Method | Purified |
| Gene Alias | 2010004A03Rik; AI593503; C16orf77; IL34; IL-34; ILN; Interleukin; interleukin 34; Interleukin34; interleukin-34 |
| Product Type | Protein |
| Gene ID (Entrez) | 146433 |
| Formulation | Protein with no preservative |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-2 |
| Molecular Weight (g/mol) | 15.5 kDa |
| Gene Symbol | IL2 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MAPTSSSTKK TQLQLEHLLL DLQMILNGIN NYKNPKLTRM LTFKFYMPKK ATELKHLQCL EEELKPLEEV LNLAQSKNFH LRPRDLISNI NVIVLELKGS ETTFMCEYAD ETATIVEFLN RWITFAQSII STLT |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,ELISA Standard,Western Blot Control |
| Source | E. coli |
| Name | Human IL-2 |
| Accession Number | P60568 |
| Gene Alias | aldesleukin; cytokine; H-IL-2; il 2; Il2; Il-2; ILN; Interleukin; interleukin 2; interleukin 2 precursor; interleukin 2 variant IL2delta2; Interleukin2; Interleukin-2; interleukin-2 precursor; interleukin-2 precursor protein; interleukin-2; interleukin 2; Involved in regulation of T cell clonal expansion; involved in regulation of T-cell clonal expansion; lymphokine; M-IL-2; patial sequence of Interleukin-2; POIL2; porcine Interleukin 2; T cell growth factor; T-cell growth factor; T-cell growth factor (TCGF); TCGF |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of murine CTLL-2 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 3558 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 46 kDa |
| Common Name | Noggin |
| Gene Symbol | NOG |
| Activity | Determined by its ability to inhibit 5.0 ng/ml of BMP-4 induced alkaline phosphatase production by ATDC-5 chondrogenic cells. The expected ED50 for this effect is 2.0-3.0 ng/ml of Noggin. |
| Endotoxin Concentration | <1 EU/μg |
| Storage Requirements | -20°C |
| Sequence | QHYLHIRPAP SDNLPLVDLI EHPDPIFDPK EKDLNETLLR SLLGGHYDPG FMATSPPEDR PGGGGGAAGG AEDLAELDQL LRQRPSGAMP SEIKGLEFSE GLAQGKKQRL SKKLRRKLQM WLWSQTFCPV LYAWNDLGSR FWPRYVKVGS CFSKRSCSVP EGMVCKPSKS VHLTVLRWRC QRRGGQRCGW IPIQYPIISE CKCSC |
| Expression System | HEK293 cells |
| For Use With (Application) | Bioactivity,Control |
| Name | Human Noggin |
| Accession Number | Q13253 |
| Purification Method | Purified |
| Gene Alias | NOG; Noggin; Noggin precursor; noggin; LOW QUALITY PROTEIN: noggin; SYM1; symphalangism 1 (proximal); SYNS1; SYNS1A |
| Product Type | Protein |
| Gene ID (Entrez) | 9241 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |